CA 19-9 test cost in Las Vegas, NV — inpatient
In Las Vegas-Henderson-North Las Vegas, NV, 1 hospital lists a cash price for CA 19-9 blood test (tumor marker) as an inpatient: from $87.30 to $87.30, with a median of $87.30. Across Nevada, the median is $36.29 at 5 hospitals.
Cash prices at 1 facility for code 86301, as an inpatient (admitted to hospital) . Collected Sep 23, 2026; the hospital files themselves were last updated between Jul 1, 2026 and Jul 1, 2026.
Hospitals, cheapest first
| Hospital | Cash price | List price | Insurers pay | Off list | File date |
|---|---|---|---|---|---|
| University Medical Center of Southern Nevada Las Vegas, NV · (702) 383-2000 HC IA QUANT; CA 19 - 9 | $87.30 | $291.00 | $10.03–$247.35 | 70% | Jul 1, 2026 source file |
Inpatient: lowest $87.30, median $87.30, highest $87.30.
As an outpatient, the same code is billed by 2 facilities here, median $53.65 — that is the price to compare if you are not being admitted.
Cash or insurance?
At the one hospital here that publishes insurer rates for this code, the cash price is below the highest rate a health plan has negotiated. If you have insurance but have not met your deductible, you usually pay your plan's negotiated rate, which falls somewhere in the "Insurers pay" column. Paying cash can cost less, but a cash payment usually does not count toward your deductible. Ask the hospital for both numbers before you book.
What it is
CA 19-9 is a tumor marker used mainly to follow pancreatic and bile duct cancers during treatment.
What the price covers
The price usually covers running the test. The blood draw (36415) is often billed as a separate line.